December 21, 2014 1:54 PM ET

Biotechnology

Company Overview of XY, Inc.

Company Overview

XY, Inc., a biotechnology company, engages in the research, development, and commercialization of sex-selection techniques in non-human mammals in the United Kingdom, the United States, Mexico, Argentina, Canada, Brazil, and China. The company focuses on cattle, horses, pigs, and endangered species. XY, Inc. was founded in 1996 and is headquartered in Fort Collins, Colorado. As of May 15, 2007, XY, Inc. operates as a subsidiary of Inguran, LLC.

1108 North Lemay Avenue

Fort Collins, CO 80524

United States

Founded in 1996

Phone:

970-493-3113

Fax:

970-493-3114

Key Executives for XY, Inc.

Chairman
Age: 72
General Manager
Reproductive Physiologist
Trainer
Instrumentation Specialist
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Forticell Bioscience, Inc. United States
Xenotope Diagnostics Inc. United States
Therapeutic Systems Research Laboratories, Inc. United States
BioLegend, Inc. United States
Neurolixis, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XY, Inc., please visit www.xyinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.